Venrock Healthcare Capital Partners Discloses 7.1% Stake in Biocryst Pharmaceuticals Inc (BCRX)

Page 11 of 19

Page 11 of 19 – SEC Filing
CUSIP No. 09058V103     Page 11 of 15
 
(d)
Title of Class of Securities
Common Stock, $0.01 par value
 
 
(e)
CUSIP Number
09058V103
 
Item 3.
If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
Not applicable
 
Item 4.
Ownership
  (a) Amount Beneficially Owned as of March 28, 2016:
Venrock Healthcare Capital Partners, L.P.
5,241,378(1)
   
VHCP Co-Investment Holdings, LLC
 5,241,378(1)
   
Venrock Healthcare Capital Partners II, L.P.
5,241,378(1)
   
VHCP Co-Investment Holdings II, LLC
 5,241,378(1)
   
VHCP Management, LLC
5,241,378(1)
 
VHCP Management II, LLC
5,241,378(1)
   
Anders Hove
5,241,378(1)
    Bong Koh
5,241,378(1)
 
(b) Percent of Class as of March 28, 2016:
   
Venrock Healthcare Capital Partners, L.P.
7.1% (2)
   
VHCP Co-Investment Holdings, LLC
 7.1% (2)
   
Venrock Healthcare Capital Partners II, L.P.
7.1% (2)
   
VHCP Co-Investment Holdings II, LLC
7.1% (2)
   
VHCP Management, LLC
7.1% (2)
   
VHCP Management II, LLC
7.1% (2)
   
Anders Hove
7.1% (2)
    Bong Koh
7.1% (2)
 
(c)
Number of shares as to which the person has, as of March 28, 2016:
(i) Sole power to vote or to direct the vote  
   
Venrock Healthcare Capital Partners, L.P.
0
   
VHCP Co-Investment Holdings, LLC
0
   
Venrock Healthcare Capital Partners II, L.P.
0
   
VHCP Co-Investment Holdings II, LLC
0
   
VHCP Management, LLC
0
   
VHCP Management II, LLC
0
   
Anders Hove
0
    Bong Koh
0
 
 

Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)

Page 11 of 19